BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 159 found
  Current Search:  delta: 159     

HTML
100%
Resolvyx Scientific Advisors Publish First In-Vivo Data Showing Resolvins Suppress IL-23 and IL-17, Key Mediat
- Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced that a research team led by a Resolvyx scientific advisor and a company co-founder has demonstrated that the resolvin E1 (RvE1) effectively...
DiGiTAL50:  Jul 4 2008 7:43AM
Matching: delta
Find similar documents
HTML
100%
Resolvyx Scientific Advisors Publish First In-Vivo Data Showing Resolvins Suppress IL-23 and IL-17, Key Mediat
- Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced that a research team led by a Resolvyx scientific advisor and a company co-founder has demonstrated that the resolvin E1 (RvE1) effectively...
Pharma Live:  Jul 4 2008 6:21AM
Matching: delta
Find similar documents
HTML
100%
Delta T Controlled Culture Dish System
Finally a culture dish system specifically designed for live-cell microscopy Details Finally a culture dish system specifically designed for live-cell microscopy!

Now you can have accurate temperature control and high numeric aperture...

Drug Discovery Online:  Jul 3 2008 3:45AM
Matching: delta
Find similar documents
HTML
100%
Resolvyx Scientific Advisors Publish First In-Vivo Data Showing Resolvins Suppress IL-23 and IL-17, Key Mediat
- Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced that a research team led by a Resolvyx scientific advisor and a company co-founder has demonstrated that the resolvin E1 (RvE1) effectively...
Therapeutics Daily:  Jul 3 2008 1:02PM
Matching: delta
Find similar documents
HTML
100%
Resolvyx Scientific Advisors Publish First In-Vivo Data Showing Resolvins Suppress IL-23 and IL-17, Key Mediat
Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced that a research team led by a Resolvyx scientific advisor and a company co-founder has demonstrated that the resolvin E1 (RvE1) effectively suppresses...
Genetic Engineering News:  Jul 3 2008 12:39PM
Matching: delta
Find similar documents
HTML
100%
Omega T Series Tangential Flow Filtration Membrane Cassettes
Filtration- Molded radii face edge: Smooth surface to actuate gasket seal Radii corners- Easier to clean Details Features and Benefits Molded radii face edge: Smooth surface to actuate gasket seal Radii corners: Easier to clean Increased...
Drug Discovery Online:  Jul 3 2008 3:58AM
Matching: delta
Find similar documents
HTML
100%
Delta Pinestone shares a dream for Dawson
By JENN WATT Posted 11 hours ago Dawson's Dream committee took a giant leap toward an incredibly giant goal at Delta Pinestone Resort on Sunday.

Starting with zero dollars in the bank, the group launched the day of family events to...

Minden Times:  Jul 2 2008 10:19PM
Matching: delta
Find similar documents
HTML
100%
Purina giving $400,000 to Delta Society
Purina giving $400,000 to Delta Society.
DVM 360:  Jul 2 2008 5:52AM
Matching: delta
Find similar documents
HTML
100%
Population Pharmacokinetic Modeling of Epoetin Delta in Pediatric Patients With Chronic Kidney Disease
William Knebel, PharmD, PhD, Mary Palmen, PhD, James A.

Dowell, PhD and Marc Gastonguay, PhD From Metrum Research Group LLC, Tariffville, Connecticut (Dr Knebel, Dr Gastonguay), and Shire Pharmaceuticals, Basingstoke, Hampshire, UK (Dr...

The Journal of Clinical Pharmacology:  Jul 1 2008 1:27AM
Matching: delta
Find similar documents
HTML
100%
Pain management for oral surgery in dogs and cats
Pain from tissue insult involves a complicated array of physiologic and chemical changes that lead to perception in the brain.

Understanding the terminology and physiology and managing oral pain in our patients is the focus of this series....

DVM 360:  Jul 1 2008 5:00PM
Matching: delta
Find similar documents
HTML
100%
Analgesics for oral surgery in dogs and cats
Six of the most common agents used for managing pain associated with oral surgery in dogs and cats will be discussed in this third article of a series on pain management.

They are the opioids (opiates), the Cox-2 selective non-steroidal...

DVM 360:  Jul 1 2008 4:59PM
Matching: delta
Find similar documents
HTML
100%
Analog Devices Sigma-Delta Converter is Unmatched in Speed and Resolution for Precision Sensing
, 8:00 AM EST News source: Business Wire Analog Devices, Inc.

(NYSE: ADI), the global leader in data converter technology, is enabling industrial equipment manufacturers to expand the operating speed and precision of sensitive measurement...

Genetic Engineering News:  Jun 30 2008 1:17PM
Matching: delta
Find similar documents
HTML
100%
Cancer Center of Greenwood Receptionist Featured in Greenwood Commonwealth
-- Stacy Corley, receptionist at Cancer Center of Greenwood, shares information about herself and job position in a recent edition of the Greenwood Commonwealth newspaper.

The daily newspaper provides information on local news, sports,...

PR-USA.net:  Jun 30 2008 2:29AM
Matching: delta
Find similar documents
HTML
100%
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Gen
Preclinical Animal Data Demonstrates Promising Therapeutic Strategy for HIV/AIDS RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

(Nasdaq: SGMO - News) announced today the publication of data demonstrating that...

Yahoo!:  Jun 30 2008 12:02PM
Matching: delta
Find similar documents
HTML
100%
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Gen
Preclinical Animal Data Demonstrates Promising Therapeutic Strategy for HIV/AIDS RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

(Nasdaq: SGMO) announced today the publication of data demonstrating that human...

PR Newswire:  Jun 30 2008 11:53AM
Matching: delta
Find similar documents
HTML
100%
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Gen
RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

(Nasdaq: SGMO) announced today the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by...

Columbus Business First:  Jun 30 2008 11:50AM
Matching: delta
Find similar documents
HTML
100%
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Gen
RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

(Nasdaq: SGMO) announced today the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by...

Cincinnati Business Journal:  Jun 30 2008 11:39AM
Matching: delta
Find similar documents
HTML
100%
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Gen
RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

(Nasdaq: SGMO) announced today the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by...

Portland Business Journal:  Jun 30 2008 11:29AM
Matching: delta
Find similar documents
HTML
100%
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Gen
RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

(Nasdaq: SGMO) announced today the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by...

Biz Journals:  Jun 30 2008 11:27AM
Matching: delta
Find similar documents
HTML
100%
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Gen
RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

SGMO announced today the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by treatment with...

Houston Chronicle:  Jun 30 2008 11:25AM
Matching: delta
Find similar documents
HTML
100%
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Gen
RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

(Nasdaq: SGMO) announced today the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by...

The Business Journal Phoenix:  Jun 30 2008 11:23AM
Matching: delta
Find similar documents
HTML
100%
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Gen
Preclinical Animal Data Demonstrates Promising Therapeutic Strategy for HIV/AIDS RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

(Nasdaq: SGMO) announced today the publication of data demonstrating that human...

Breitbart.com:  Jun 30 2008 11:20AM
Matching: delta
Find similar documents
HTML
100%
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Gen
RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

(Nasdaq: SGMO) announced today the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by...

Twin Cities Business Journal:  Jun 30 2008 11:19AM
Matching: delta
Find similar documents
HTML
100%
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Gen
Author : Sangamo BioSciences, Inc.

Category : Press Release News Alerts by Email click here ) News | Home Preclinical Animal Data Demonstrates Promising Therapeutic Strategy for HIV/AIDS RICHMOND, Calif., June 30 RICHMOND, Calif., June 30 ...

Earthtimes.org:  Jun 30 2008 11:19AM
Matching: delta
Find similar documents
HTML
100%
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Gen
RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.

announced today the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by treatment with zinc...

Stockwatch:  Jun 30 2008 11:18AM
Matching: delta
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.